AKUMS
Invest with MTF
Invest Now
Invest in Akums Drugs & Pharmaceuticals with 3.29X leverage
Performance
- Low
- ₹437
- High
- ₹446
- 52 Week Low
- ₹405
- 52 Week High
- ₹636
- Open Price₹443
- Previous Close₹444
- Volume96,072
- 50 DMA₹442.49
- 100 DMA₹456.10
- 200 DMA₹503.68
Investment Returns
- Over 1 Month + 3.63%
- Over 3 Month -5.28%
- Over 6 Month -20.89%
- Over 1 Year -30.88%
Smart Investing Starts Here Start SIP with Akums Drugs & Pharmaceuticals for Steady Growth!
Akums Drugs & Pharmaceuticals Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.
- P/E Ratio
- 21.7
- PEG Ratio
- 1.5
- Market Cap Cr
- 6,884
- P/B Ratio
- 2.2
- Average True Range
- 10.35
- EPS
- 19.54
- Dividend Yield
- 0
- MACD Signal
- 3.33
- RSI
- 45.88
- MFI
- 50.3
Akums Drugs & Pharmaceuticals Financials
Akums Drugs & Pharmaceuticals Technicals
EMA & SMA
Current Price
₹437.35
-6.75
(-1.52%)
- Bearish Moving Average 15
- Bullish Moving Average 1
- 20 Day
- ₹442.62
- 50 Day
- ₹442.49
- 100 Day
- ₹456.10
- 200 Day
- ₹503.68
Resistance and Support
440.05
- R3 451.90
- R2 448.85
- R1 443.10
- S1 434.30
- S2 431.25
- S3 425.50
Akums Drugs & Pharmaceuticals Corporate Actions - Bonus, Splits, Dividends
| Date | Purpose | Remarks |
|---|---|---|
| 2025-11-13 | Quarterly Results | |
| 2025-08-08 | Quarterly Results | |
| 2025-05-26 | Audited Results | |
| 2025-02-06 | Quarterly Results | |
| 2024-11-09 | Quarterly Results |
Akums Drugs & Pharmaceuticals F&O
About Akums Drugs & Pharmaceuticals
- NSE Symbol
- AKUMS
- BSE Symbol
- 544222
- Managing Director
- Mr. Sanjeev Jain
- ISIN
- INE09XN01023
Similar Stocks to Akums Drugs & Pharmaceuticals
Akums Drugs & Pharmaceuticals FAQs
Akums Drugs & Pharmaceuticals share price is ₹437 As on 19 January, 2026 | 23:18
The Market Cap of Akums Drugs & Pharmaceuticals is ₹6883.6 Cr As on 19 January, 2026 | 23:18
The P/E ratio of Akums Drugs & Pharmaceuticals is 21.7 As on 19 January, 2026 | 23:18
The PB ratio of Akums Drugs & Pharmaceuticals is 2.2 As on 19 January, 2026 | 23:18
Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.